Nevro Corp.

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. The Nevro® Senza® SCS system received CE Mark in 2010, TGA Approval in 2011, FDA Approval in 2015, and is commercially available in Europe, Australia, and the United States.
Company Growth (employees)
Type
Public
HQ
Redwood City, US
Founded
2006
Size (employees)
518 (est)
Website
nevro.com
Nevro Corp. was founded in 2006 and is headquartered in Redwood City, US

Nevro Corp. Office Locations

Nevro Corp. has an office in Redwood City
Redwood City, US (HQ)
1800 Bridge Pkwy

Nevro Corp. Data and Metrics

Nevro Corp. Financial Metrics

Nevro Corp.'s revenue was reported to be $68.4 m in Q1, 2017
USD

Revenue (Q1, 2017)

68.4 m

Gross profit (Q1, 2017)

46.4 m

Gross profit margin (Q1, 2017), %

68%

Net income (Q1, 2017)

(14.5 m)

EBIT (Q1, 2017)

(13.1 m)

Market capitalization (18-Aug-2017)

2.5 b

Cash (31-Mar-2017)

19.2 m
Nevro Corp.'s current market capitalization is $2.5 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

32.6 m69.6 m228.5 m

Revenue growth, %

114%228%

Cost of goods sold

11.3 m28.1 m75.4 m

Gross profit

21.3 m41.5 m153.1 m

Gross profit Margin, %

65%60%67%

R&D expense

19.8 m21.4 m33.7 m

Operating expense total

19.8 m33.7 m

EBIT

(28.3 m)(62.4 m)(23.1 m)

EBIT margin, %

(87%)(90%)(10%)

Interest expense

16 k2.7 m6.4 m

Interest income

16 k575 k1.7 m

Pre tax profit

(30.2 m)(66.3 m)(30.2 m)

Income tax expense

478 k1.2 m1.6 m

Net Income

(30.7 m)(67.4 m)(31.8 m)
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

8.7 m9.7 m11.4 m15.4 m41.7 m55.4 m60.9 m68.4 m

Cost of goods sold

2.7 m3.9 m5.5 m6 m15.7 m18.8 m19.2 m22.1 m

Gross profit

5.9 m5.8 m5.9 m9.4 m26 m36.6 m41.7 m46.4 m

Gross profit Margin, %

68%60%52%61%62%66%68%68%

R&D expense

5.2 m5 m5.3 m5.2 m6.4 m8.2 m7.9 m8.7 m

EBIT

(6.5 m)(12.3 m)(19.2 m)(17.7 m)(9 m)(5.9 m)(1.9 m)(13.1 m)

EBIT margin, %

(75%)(128%)(168%)(115%)(22%)(11%)(3%)(19%)

Interest income

20 k104 k110 k185 k215 k295 k556 k709 k

Pre tax profit

(7.7 m)(13.9 m)(19.6 m)(19.2 m)(9 m)(8.5 m)(3.4 m)(14.2 m)

Net Income

(7.9 m)(14.1 m)(19.7 m)(19.5 m)(9.3 m)(8.8 m)(3.9 m)(14.5 m)
USDFY, 2014FY, 2015FY, 2016

Cash

25.3 m87 m41.4 m

Accounts Receivable

22.5 m52.8 m

Inventories

62.4 m85.2 m

Current Assets

201.1 m282.6 m420.3 m

PP&E

647 k5.8 m7.1 m

Total Assets

202.5 m291.2 m430.6 m

Accounts Payable

7.1 m21.9 m16.2 m

Total Debt

39 m39.5 m138.1 m

Current Liabilities

10.8 m36.4 m42.2 m

Total Liabilities

181.5 m

Additional Paid-in Capital

293.9 m424.1 m470.9 m

Retained Earnings

(122 m)(189.4 m)(221.2 m)

Total Equity

172.1 m234.6 m249 m

Debt to Equity Ratio

0.2 x0.2 x0.6 x

Debt to Assets Ratio

0.2 x0.1 x0.3 x

Financial Leverage

1.2 x1.2 x1.7 x
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

14.5 m22 m58.7 m87.6 m48.8 m50.7 m42.7 m19.2 m

Inventories

12.1 m18.2 m26.4 m42.7 m67.6 m68.1 m73.4 m84.7 m

Current Assets

53.5 m187.8 m291.5 m279.2 m265.9 m402.5 m408.9 m407.4 m

PP&E

289 k1.2 m2.8 m5.7 m5.9 m6.7 m7.6 m7.4 m

Total Assets

56.1 m192.2 m297.3 m287.7 m274.5 m412.3 m419.9 m417.9 m

Accounts Payable

3.5 m8.2 m7.3 m12.9 m11.8 m13.1 m13.1 m12.1 m

Current Liabilities

8.7 m13.4 m16 m23.5 m25.4 m30.6 m34.6 m34.2 m

Additional Paid-in Capital

7.7 m295.3 m417.1 m419.6 m427.8 m454.2 m460 m479.1 m

Retained Earnings

(113.7 m)(136 m)(155.8 m)(175.2 m)(198.7 m)(207.5 m)(211.4 m)(235.7 m)

Total Equity

(106 m)159.1 m261.5 m244.3 m228.8 m246.4 m247.7 m242.5 m

Financial Leverage

-0.5 x1.2 x1.1 x1.2 x1.2 x1.7 x1.7 x1.7 x
USDFY, 2014FY, 2015FY, 2016

Net Income

(30.7 m)(67.4 m)(31.8 m)

Depreciation and Amortization

96 k614 k1.7 m

Accounts Receivable

167 k(16.2 m)(32.2 m)

Inventories

(5.5 m)(49.4 m)(27 m)

Accounts Payable

1.3 m17.1 m(5.6 m)

Cash From Operating Activities

(31.1 m)(100.4 m)(58.5 m)

Purchases of PP&E

(625 k)(5 m)(3.4 m)

Cash From Investing Activities

(108.1 m)39.7 m(131.7 m)

Long-term Borrowings

(19.5 m)

Cash From Financing Activities

152.1 m122.8 m145.2 m

Interest Paid

2.3 m2.5 m

Income Taxes Paid

670 k492 k
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(7.9 m)(14.1 m)(19.7 m)(19.5 m)(9.3 m)(8.8 m)(3.9 m)(14.5 m)

Inventories

67.6 m68.1 m73.4 m84.7 m

Accounts Payable

3.5 m8.2 m7.3 m12.9 m11.8 m13.1 m13.1 m12.1 m
USDY, 2017

Revenue/Employee

132.1 k

Financial Leverage

1.7 x

Nevro Corp. Operating Metrics

FY, 2016

Patents Issued

132

Patents Pending

101

Trademarks

16

Nevro Corp. Market Value History

Traffic Overview of Nevro Corp.

Nevro Corp. Online and Social Media Presence

Nevro Corp. Company Life and Culture

You may also be interested in